Clinical Trials Logo

Cigarette Smoker clinical trials

View clinical trials related to Cigarette Smoker.

Filter by:

NCT ID: NCT04060446 Completed - Cigarette Smoker Clinical Trials

Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers

Start date: June 6, 2019
Phase:
Study type: Observational

This trial examines the effects of filter ventilation on sensory response, smoking topography, and inhalation in current every day cigarette smokers. The physical design features of cigarettes directly impact their appeal by influencing cognitive and sensory perceptions. The introduction of a now common design feature, filter ventilation, has led to greater public harm than benefit because of the potential for greater toxicity while enhancing product appeal among smokers. Ventilated cigarettes dilute smoke, which promotes perceptions of ?smoothness? and therefore lower health risk, contributing to the overall appeal of these products. The purpose of this study is to assess whether removing ventilation from cigarette filters lowers cigarette product appeal among smokers.

NCT ID: NCT03865472 Recruiting - Cigarette Smoker Clinical Trials

rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.

NCT ID: NCT03824535 Recruiting - Clinical trials for Multiple Pulmonary Nodules

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Start date: February 4, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.

NCT ID: NCT03691350 Recruiting - Cigarette Smoker Clinical Trials

Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs

Start date: September 17, 2018
Phase: Early Phase 1
Study type: Interventional

This trial studies biomarkers obtained by bronchoscopy (bronchoalveolar lavage and lung brushings) to determine the effect of smoking e-cigarettes on the lungs. Studying samples of lung cells from participants who smoke e-cigarettes may help doctors learn more about changes that occur in deoxyribonucleic acid and identify biomarkers related to cancer.

NCT ID: NCT03669120 Completed - Cigarette Smoker Clinical Trials

Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking

Start date: August 10, 2018
Phase: N/A
Study type: Interventional

This trial studies how well tailored smoking cessation intervention works in promoting sexual and gender minority smokers to quit smoking. A program that is specifically designed for the lesbian, gay, bisexual, and transgender community may affect these participants differently than a traditional approach.

NCT ID: NCT03668769 Withdrawn - Malignant Neoplasm Clinical Trials

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

Start date: March 27, 2017
Phase: N/A
Study type: Interventional

This trial studies how well a mobile smartphone application called Quitting Schedule works in helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a computer-based initiative that offered state of-the-art smoking cessation treatment and counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for non-patients to find information regarding smoking cessation advice and treatments. Quitting Schedule may help participants to quit smoking.

NCT ID: NCT03199651 Recruiting - Clinical trials for Stage IV Non-Small Cell Lung Cancer

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

BLCIO
Start date: July 17, 2017
Phase: N/A
Study type: Interventional

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival, have more favorable toxicity profiles than conventional chemotherapy and impact quality of life.

NCT ID: NCT02697227 Active, not recruiting - Clinical trials for Tobacco Use Disorder

Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation

Start date: August 5, 2016
Phase: N/A
Study type: Interventional

This randomized clinical trial studies how well behavioral activation therapy and nicotine replacement therapy work in increasing smoking cessation. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Giving behavioral activation therapy and nicotine replacement therapy may help patients quit smoking or change their smoking behavior.

NCT ID: NCT02575885 Completed - Healthy Subject Clinical Trials

Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers

ENDS
Start date: March 16, 2016
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies nicotine delivery from novel non-tobacco electronic system (ENDS) in smokers. Studying the levels of nicotine delivered by various types and brands of ENDS to the bloodstream, and comparing this to the levels delivered from conventional cigarettes (the participant's own brand) may help provide information about the use of nicotine-containing products that may help inform/reform current tobacco policy, practice, and harm reduction approaches.

NCT ID: NCT02271919 Active, not recruiting - Clinical trials for Tobacco Use Disorder

Varenicline and Combined NRT for Smoking Cessation

Start date: May 14, 2015
Phase: Phase 4
Study type: Interventional

This randomized pilot phase IV trial studies the side effects and how well varenicline works compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine replacement therapy consists of nicotine patches and lozenges. It is not yet known if varenicline is more effective than nicotine replacement therapy in helping patients quit smoking.